tiprankstipranks
Trending News
More News >
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market
Advertisement

Acura Pharmaceuticals (ACUR) Income Statement

Compare
81 Followers

Acura Pharmaceuticals Income Statement

Last quarter (Q4 2021), Acura Pharmaceuticals's total revenue was $36.00K, a decrease of -94.99% from the same quarter last year. In Q4, Acura Pharmaceuticals's net income was $29.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.56M$ 3.57M$ 2.66M$ 410.00K$ 2.97M
Gross Profit
$ 352.00K$ 3.57M$ 2.65M$ 408.24K$ 2.84M
Operating Expenses
$ 1.25M$ 4.33M$ 3.38M$ 4.33M$ 8.06M
Depreciation and Amortization
$ 90.00K$ 125.00K$ 273.00K$ 280.00K$ 294.00K
EBITDA
$ -589.00K$ -633.00K$ -3.04M$ -3.17M$ -4.93M
Operating Income
$ -1.21M$ -758.00K$ -725.00K$ -3.92M$ -5.22M
Other Income/Expenses
$ 335.00K$ -450.00K$ -3.05M$ 73.00K$ -592.00K
Pretax Income
$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.82M
Net Income
$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.68M
Per Share Metrics
Basic EPS
$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Diluted EPS
$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Weighted Average Shares Outstanding
43.95M 30.20M 26.72M 21.15M 15.90M
Weighted Average Shares Outstanding (Diluted)
56.80M 32.32M 26.72M 21.15M 15.90M
Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis